BNGO - Bionano Genomics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BNGO is currently covered by 4 analysts with an average price target of $802.09. This is a potential upside of $798.44 (21875.07%) from yesterday's end of day stock price of $3.65.

Bionano Genomics's activity chart (see below) currently has 8 price targets and 33 ratings on display. The stock rating distribution of BNGO is 57.14% BUY and 42.86% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 51.33% with an average time for these price targets to be met of 88.6 days.

Highest price target for BNGO is $8, Lowest price target is $4, average price target is $6.

Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 20-May-2025. First documented stock forecast 08-Apr-2020.

Best performing analysts who are covering BNGO - Bionano Genomics:

Kevin Degeeter Sung Ji Nam Jay Cohen Mark Massaro Jason Mccarthy

Currently out of the existing stock ratings of BNGO, 8 are a BUY (57.14%), 6 are a HOLD (42.86%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$8

$4.28 (115.05%)

9 days ago
(20-May-2025)

1/2 (50%)

$4.23 (112.20%)

25

Hold

$4

$0.28 (7.53%)

$60

1 months 27 days ago
(02-Apr-2025)

2/5 (40%)

$0.25 (6.67%)

8

Hold

$120

8 months 19 days ago
(10-Sep-2024)

1/3 (33.33%)

$53.4 (80.18%)

69

Buy

$80

2 years 4 months 25 days ago
(05-Jan-2023)

2/3 (66.67%)

$58.3 (268.66%)

204

Buy

2 years 10 months 11 days ago
(18-Jul-2022)

2/3 (66.67%)

$3876 (85.68%)

137

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BNGO (Bionano Genomics) average time for price targets to be met?

On average it took 88.6 days on average for the stock forecasts to be realized with a an average price target met ratio 51.33

Which analyst has the current highest performing score on BNGO (Bionano Genomics) with a proven track record?

KEVIN DEGEETER

Which analyst has the current lower performing score on BNGO (Bionano Genomics) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on BNGO (Bionano Genomics)?

Kevin Degeeter has 4 price targets and 3 ratings on BNGO

Which analyst is the currently most bullish on BNGO (Bionano Genomics)?

Jason Mccarthy with highest potential upside - $4.28

Which analyst is the currently most reserved on BNGO (Bionano Genomics)?

Kevin Degeeter with lowest potential downside - -$0

Bionano Genomics in the News

International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers

SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) — Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), today announced the publication in the American Journal of Hematology of expert recommendations from the International Consortium for Optical Genome Mapping (ICOGM) for the...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?